Article
Resolution of fibrosis in mdx dystrophic mouse after oral consumption of N-163 strain of…
medRxiv · 2022 · Preethy, S.; Aoki, Y.; Minegishi, K.; Iwasaki, M.; Senthilkumar, R.; Abraham, S. J.
Key facts
| Title | Resolution of fibrosis in mdx dystrophic mouse after oral consumption of N-163 strain of Aureobasidium pullulans produced biological response modifier β-glucan (BRMG)` |
|---|---|
| First author | Preethy, S.; Aoki, Y.; Minegishi, K.; Iwasaki, M.; Senthilkumar, R.; Abraham, S. J. |
| Journal | medRxiv |
| Published | Nov 17, 2022 |
| DOI | 10.1101/2022.11.17.516628 |
| Product codes mentioned | ICC |
At a glance
- None FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1